Ohkura N - Search Results

1

Prostaglandin A2 acts as a transactivator for NOR1 (NR4A3) within the nuclear receptor superfamily.

Kagaya S, Ohkura N, Tsukada T, Miyagawa M, Sugita Y, Tsujimoto G, Matsumoto K, Saito H, Hashida R. Kagaya S, et al. Among authors: ohkura n. Biol Pharm Bull. 2005 Sep;28(9):1603-7. doi: 10.1248/bpb.28.1603. Biol Pharm Bull. 2005. PMID: 16141523 Free article.

2

NR4A orphan nuclear receptor family in peripheral blood eosinophils from patients with atopic dermatitis and apoptotic eosinophils in vitro.

Kagaya S, Hashida R, Ohkura N, Tsukada T, Sugita Y, Terakawa M, Tsujimoto G, Katsunuma T, Akasawa A, Matsumoto K, Saito H. Kagaya S, et al. Among authors: ohkura n. Int Arch Allergy Immunol. 2005;137 Suppl 1:35-44. doi: 10.1159/000085430. Epub 2005 Jun 2. Int Arch Allergy Immunol. 2005. PMID: 15947483

3

The NR4A nuclear receptor family in eosinophils.

Hashida R, Ohkura N, Saito H, Tsujimoto G. Hashida R, et al. Among authors: ohkura n. J Hum Genet. 2007;52(1):13-20. doi: 10.1007/s10038-006-0085-2. Epub 2006 Nov 10. J Hum Genet. 2007. PMID: 17096060 Review.

4

The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing.

Ohkura N, Yaguchi H, Tsukada T, Yamaguchi K. Ohkura N, et al. J Biol Chem. 2002 Jan 4;277(1):535-43. doi: 10.1074/jbc.M109018200. Epub 2001 Oct 22. J Biol Chem. 2002. PMID: 11673470 Free article.

5

Coactivator-associated arginine methyltransferase 1, CARM1, affects pre-mRNA splicing in an isoform-specific manner.

Ohkura N, Takahashi M, Yaguchi H, Nagamura Y, Tsukada T. Ohkura N, et al. J Biol Chem. 2005 Aug 12;280(32):28927-35. doi: 10.1074/jbc.M502173200. Epub 2005 Jun 8. J Biol Chem. 2005. PMID: 15944154 Free article.

6

Differential transactivation by orphan nuclear receptor NOR1 and its fusion gene product EWS/NOR1: possible involvement of poly(ADP-ribose) polymerase I, PARP-1.

Ohkura N, Nagamura Y, Tsukada T. Ohkura N, et al. J Cell Biochem. 2008 Oct 15;105(3):785-800. doi: 10.1002/jcb.21876. J Cell Biochem. 2008. PMID: 18680143

7

Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23.

Yaguchi H, Ohkura N, Tsukada T, Yamaguchi K. Yaguchi H, et al. Among authors: ohkura n. J Biol Chem. 2002 Oct 11;277(41):38197-204. doi: 10.1074/jbc.M204132200. Epub 2002 Jul 26. J Biol Chem. 2002. PMID: 12145286 Free article.

8

Gene dose mapping delineated boundaries of a large germline deletion responsible for multiple endocrine neoplasia type 1.

Kikuchi M, Ohkura N, Yamaguchi K, Obara T, Tsukada T. Kikuchi M, et al. Among authors: ohkura n. Cancer Lett. 2004 May 10;208(1):81-8. doi: 10.1016/j.canlet.2003.10.011. Cancer Lett. 2004. PMID: 15105049

9

MEN1 gene and its mutations: basic and clinical implications.

Tsukada T, Nagamura Y, Ohkura N. Tsukada T, et al. Among authors: ohkura n. Cancer Sci. 2009 Feb;100(2):209-15. doi: 10.1111/j.1349-7006.2008.01034.x. Cancer Sci. 2009. PMID: 19068082 Free PMC article. Review.

10

Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms.

Shimazu S, Nagamura Y, Yaguchi H, Ohkura N, Tsukada T. Shimazu S, et al. Among authors: ohkura n. Cancer Sci. 2011 Nov;102(11):2097-102. doi: 10.1111/j.1349-7006.2011.02055.x. Epub 2011 Sep 1. Cancer Sci. 2011. PMID: 21819486 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters